Xuejia Zhai

Dr. Xuejia Zhai


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2018 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
YQYanjie Qin
Yanjie Qin
NWNanxi Wang
Nanxi Wang
XZXinlin Zhang
Xinlin Zhang
XHXuemei Han
Xuemei Han
XZXuejia Zhai
Xuejia Zhai
YLYongning Lu
Yongning Lu

1 September 2019 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
XHXue-Mei Han
Xue-Mei Han
YQYan-Jie Qin
Yan-Jie Qin
YZYing Zhu
Ying Zhu
XZXin-Lin Zhang
Xin-Lin Zhang
NWNan-Xi Wang
Nan-Xi Wang
YLYongning Lu
Yongning Lu

13 June 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
JTJingxuan Tan
Jingxuan Tan
XLXixuan Li
Xixuan Li
YZYing Zhu
Ying Zhu
MSMitchell A. Sullivan
Mitchell A. Sullivan
BDBin Deng
Bin Deng
YLYongning Lu
Yongning Lu
Shugan Jieyu Capsule (SG) has been widely used in China to treat mild to moderate depression. Hypericum perforatum L. (St John’s Wort, SJW) is the main ingredient of SG and has been used as herbal medicine to treat depression in western countries. However, it is known that SJW has low bioavailability and does not easily get through the blood-brain barrier. Therefore, how SG plays an antidepressant effect in the central nervous system (CNS) remains an urgent problem to be solved. Mounting research has described the relationship between antidepressants and intestinal microbiota to illuminate antidepressive mechanisms in the CNS. We aimed to investigate the effects of therapy with SG on the function of gut microbiota and intestinal microbiota in rats with chronic unpredictable mild stress (CUMS)-induced depression. The psychophysiological state and the hypothalamic-pituitary-adrenal axis function of rats are evaluated through behavioral experiments, corticosterone levels, serotonin levels, and adrenal index measurements. 16S rDNA amplicon sequencing is used to test the changes in gut microbiota and make functional predictions of genes. With treatment of SG, the depression-like behaviors of CUMS-induced rats were reversed; the corticosterone levels and the adrenal index decreased significantly; the level of serotonin increased significantly; and the alpha and beta diversity analysis of microbiota showed an increase in the richness and uniformity of the flora were increased. SG regulated the relative abundance of Actinobacteria, Erysipelotrichaceae, Bifidobacteriaceae, Atopobiaceae, Dubosiella, and Bifidobacterium; Linear discriminant analysis effect size analysis demonstrated that Lactobacillaceae (family level), Lactobacillus (genus level), Lactobacillales (order level), Bacilli (class level), and Lactobacillus-reuteri (species level) were biomarkers in the SG group samples, and also likely to modulate metabolic pathways, such as those involved in carbohydrate metabolism, amino acid metabolism, and signal transduction. These data clearly illustrated the effect of SG on gut microbiome, thus laying the foundation for uncovering more insights on the therapeutic function of the traditional Chinese antidepressants. The potential of SG on mechanisms of antidepression to alter gut microbiota and intestinal microbiome function exposed to CUMS can be explored.

27 September 2023 in Food Science & Nutrition
Verified
Journal Article
Open access
Peng CaoPeng Cao
Peng Cao
MYMing Yue
Ming Yue
YCYuanlei Cheng
Yuanlei Cheng
MSMitchell A. Sullivan
Mitchell A. Sullivan
WCWen Chen
Wen Chen
YZYu Zhang
Yu Zhang
Non‐alcoholic steatohepatitis (NASH) is a severe inflammatory phase of the non‐alcoholic fatty liver disease (NAFLD) spectrum and can progress to advanced stages of NAFLD if left untreated. This study uses multi‐omics data to elucidate the underlying mechanism of naringenin's reported benefit in alleviating (NASH). Male mice were fed a NASH‐inducing (methionine‐choline‐deficient) MCD diet with or without naringenin supplementation for 6 weeks. Naringenin prevented NASH‐induced histopathological liver damage and reversed the abnormal levels of hepatic triglyceride (TG)/total cholesterol (TC), serum TG/TC, serum alanine aminotransferase/aspartate transaminase, and hepatic malondialdehyde and glutathione. Importantly, naringenin intervention significantly modulated the relative abundance of gut microbiota and the host metabolomic profile. We detected more than 700 metabolites in the serum and found that the gut genus levels of Anaeroplasma and the [Eubacterium] nodatum group were closely associated with xanthine, 2‐picoline, and securinine, respectively. Tuzzerella alterations showed the highest number of associations with host endogenous metabolites such as FAHFA (8:0/10:0), FFA (20:2), carnitine C8:1, tridecanedioic acid, securinine, acetylvaline, DL‐O‐tyrosine, and Phe‐Asn. This study indicates that the interplay between host serum metabolites and gut microbiota may contribute to the therapeutic effect of naringenin against NASH.

30 May 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
QYQuancheng Yang
Quancheng Yang
XZXuejia Zhai
Xuejia Zhai
YLYi Lv
Yi Lv
In recent decades, natural products derived from plants and their derivatives have attracted great interest in the field of disease treatment. Triptolide is a tricyclic diterpene extracted from Tripterygium wilfordii, a traditional Chinese medicine, which has shown excellent therapeutic potential in the fields of immune inflammation and cancer treatment. In this study, 1,106 Web-of-Science-indexed manuscripts and 1,160 Chinese-National-Knowledge-Infrastructure-indexed manuscripts regarding triptolide published between 2011 and 2021 were analyzed, mapping the co-occurrence networks of keywords and clusters using CiteSpace software. The research frontier and development trend were determined by keyword frequency and cluster analysis, which can be used to predict the future research development of triptolide. Non–small cell lung cancer (NSCLC) is most common in lung cancer patients, accounting for about 80% of all lung cancer patients. New evidence suggests that triptolide effectively inhibits the development and metastasis of NSCLC by the induction of apoptosis, reversion of EMT, and regulation of gene expression. Specifically, it acts on NF-κB, MAPKs, P53, Wnt/β-catenin, and microRNAs (miRNAs), signaling pathways and molecular mechanisms. Consequently, this article reviews the research progress of the anti-NSCLC effect of triptolide. In addition, attenuated studies on triptolide and the potential of tumor immunotherapy are also discussed.

9 May 2025 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
ZYZihe Yang
Zihe Yang
LLLinjie Li
Linjie Li
BDBin Deng
Bin Deng
YXYusen Xu
Yusen Xu
YDYujing Du
Yujing Du
XZXuejia Zhai
Xuejia Zhai